Therapeutic administration of 131I for differentiated thyroid cancer, radiation dose to ovaries and outcome of

Author： Garsi J. P.   Schlumberger M.   Rubino C.   Ricard M.   Labbé M.   Ceccarelli C.   Schvartz C.   Henri-Amar H.   Bardet S.   De Vathaire F.  

Publisher： Edp Sciences

E-ISSN： 1769-700x|43|5|039-039

ISSN： 0033-8451

Source： Radioprotection, Vol.43, Iss.5, 2008-09, pp. : 039-039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative 131I dose over 37 GBq

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 1, 2015-07 ,pp. : 117-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical applications of SPECT/CT after first I‐131 ablation in patients with differentiated thyroid cancer

By  

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 445-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Studying the effects of the lung mass on the absorbed dose to the lung due to the administration of 131I for therapeutic purposes

By Sajjadi Z.   Miri-Hakimabad H.   Rafat-Motavalli L.  

Radioprotection, Vol. 51, Iss. 3, 2016-09 ,pp. : 187-192

Edp Sciences

Access to resources Recommend Favorite

The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma

By Hänscheid H   Lassmann M   Buck A K   Reiners C   Verburg F A  

Physics in Medicine and Biology, Vol. 59, Iss. 10, 2014-05 ,pp. : 2353-2368

IOP Publishing

Access to resources Recommend Favorite

GONADAL EFFECT OF RADIATION FROM 131 I IN MALE PATIENTS WITH THYROID CARCINOMA

By Krassas G. E.   Pontikides N.  

Archives of Andrology, Vol. 51, Iss. 3, 2005-04 ,pp. : 171-175

Informa Healthcare

Access to resources Recommend Favorite